The Effect of 'Mindfulness of Breathing' on Chronic Migraine
Migraine is a common disabling primary headache disorder ranked as the third most prevalent disorder in the world. Chronic migraine (CM) is described as a headache occurring on 15 or more days/month for more than 3 months, which, on at least 8 days/month, has the features of a migraine headache. Chronic migraine typically evolves from episodic migraine with an annual progression rate of ~3%. CM is an important treatable cause of neurological disability . It impacts, on an average, 1.4-2.2% of the global population and imposes a significant individual and socioeconomic burden with disability scores reported to be nearly twice as high.
It is vital to make a diagnosis and ensure that any concomitant medical or psychological conditions are treated in parallel with interventions aimed at reducing the biological tendency to headaches. The conventional treatment for migraine therapy is medical therapy. However only half of the patients respond to medications and preventive drug treatments; and about 10% discontinue medications due to adverse events. Moreover almost half of the patients are not satisfied with the present treatment. There is a clear need for additional preventive strategies in the current treatment regimens for migraines due to existing shortcomings of medical management of CM. In addition, there are other tactics that can be used, such as practicing alternative medicine through Yoga and Meditation.
Meditation has been found to help in reducing stress and changing the psychological state of a person. Mindfulness meditation has been derived from Vipassana, an age old meditation technique and has been practiced since long. Buddhist literature has detailed description about the techniques of Vipassana. Mindfulness of Breathing called as 'Anapanasati Meditation', in Buddhist scriptures is the first step in the practice of Vipassana meditation. It is a technique that involves observing natural and normal breathing. As it enters and exits the body our breath acts as a connection between our conscious and unconscious minds and the voluntary and involuntary processes of our body. By observing our breath, we can gain insight into the nature of our mind and its tendency to be inconsistent and fleeting.Slowly, this technique helps develop concentration of the mind and become calm. . It is a simple and scientific method that can be easily learned. Using Mindfulness of Breathing (Anapanasati) as a tool to reduce stress can be helpful in reducing the disability associated with migraines, as stress is a common trigger for migraines.
In the present study we aim to evaluate the beneficial effects of this simple meditation technique in management of CM.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Ashish Kumar Duggal, DM
- Numero di telefono: +91 9810523332
- Email: ashishduggal2005@gmail.com
Backup dei contatti dello studio
- Nome: Kumari Archana, DM
- Numero di telefono: +91 8820924289
- Email: singharchana06@gmail.com
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:-1. All patients between 18-60 years of age fulfilling the criteria for chronic migraine as defined by ICHD -3.3 2. Patients willing to carry out meditation as prescribed. 3. Patients on a maximum of one concomitant preventive medication for not less than 3 months duration and a stable dose for at least 1 month prior to randomization.
Exclusion Criteria:-1. 1.Patients < 18 years and > 60 years of age. 2. Prior Neurologic diseases like brain tumors, dementia, seizures, encephalitis, meningitis, and stroke. 3. Patients overusing barbiturate-containing analgesics, opioids, or subjects with medical conditions attributable to medication overuse (e.g. peptic ulcer disease from overuse of nonsteroidal anti-inflammatory drugs [NSAIDS]).
4. Patients who did not complete the headache diary for more than 6 non-consecutive days during the baseline period.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Ricerca sui servizi sanitari
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Supervised Meditation Group
The 'Meditation' group will take part in structured 'Mindfulness of Breathing' meditation sessions. A total of five sessions will be conducted on days 0, 7, 14, 28 and week 8th at the Yoga Department of ABVIMS and Dr RML Hospital. These sessions will be supervised by a yoga instructor who will explain the procedure and answer any queries. The patients will then practice the meditation alongside the instructor, as described in the subsequent sections. They will also be encouraged to continue this practice daily at home, using a 20-minute audio guide featuring the voice of the 'Late Shri S.N. Goenka Ji'. Additionally, the 'Meditation group' will join a WhatsApp group for enhanced supervision by the Yoga instructor, in which members will be required to provide daily updates after their meditation sessions. If they fail to report their daily meditation, the admin would remind them to ensure that they complete it, and their queries and issues will also addressed. |
The technique taught by the late Shri S.N. Goenka Ji involved sitting with closed eyes in a quiet room with minimal distractions, maintaining a comfortable posture with the spine straight and hands resting on the thighs, without requiring any specific mudra for 20 minutes daily.The practitioner will have to observe the breath as instructed, without judging its length or type. The nature of the breath will have to be accepted as it is and should not be altered. Any thoughts that arise are to be acknowledged without judgment. If the mind wanders, one has to notice this and gently shift awareness back to the breath without clinging to it or wishing it to be different. If any pain, discomfort, or other sensations are felt, these are to be acknowledged with awareness before returning attention to the breath. The subject simply follows the instructions of a pre-recorded 'Mindfulness of Breathing Meditation (Anapana)' audio provided by the yoga instructor throughout the sessions. |
|
Comparatore fittizio: Unsupervised Meditation Group
The Unsupervised meditation/Sham group will practice meditation on their visits-on days 0, 7, 14, 28, and week 8-without any supervision. The Yoga instructor will merely guide them once to independently concentrate on their breathing. They will not be provided any audio. This will serve as a sham group for more effective comparison and ensured blinding. |
Patients were told to meditate on their own .They were not provided with any structured meditation technique. They were told to meditate in a quiet room with minimal distractions, maintaining a comfortable posture with the spine straight and hands resting on the thighs, without requiring any specific mudra for 20 minutes daily on their own without any specific instructions. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
To assess the change in headache days at 12 weeks from baseline.
Lasso di tempo: From enrollment to 12 Weeks.
|
Change in frequency of moderate-severe headache days per month from baseline (Headache-day is defined as a calendar day [00:00 to 23:59] when the patient reported > 4 continuous hours of headache in the diary) during the month 2-3. |
From enrollment to 12 Weeks.
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Change in migraine days (week 8 - 12 vs baseline)
Lasso di tempo: 12 weeks
|
12 weeks
|
|
50% responder rate
Lasso di tempo: 12 weeks
|
12 weeks
|
Altre misure di risultato
Altre misure di risultato
Misura del risultato |
Lasso di tempo |
|---|---|
|
Change in headache severity (week 8 - 12 vs baseline)
Lasso di tempo: 12 weeks
|
12 weeks
|
|
Change in number of days with acute medication use (week 8 - 12 vs baseline)
Lasso di tempo: 12 weeks
|
12 weeks
|
|
Change in PHQ-9 scores (week 8 - 12 vs baseline)
Lasso di tempo: 12 weeks
|
12 weeks
|
|
Change in MIDAS score ( week 8-12 vs baseline)
Lasso di tempo: 12 weeks
|
12 weeks
|
|
Change in HIT (week 8-12 vs baseline)
Lasso di tempo: 12 weeks
|
12 weeks
|
Collaboratori e investigatori
Sponsor
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- IEC/ABVIMS/RMLH/1410
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
IPD related to the study will be shared by the principal investigator on request.
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- LINFA
- ICF
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .